In a significant leap forward for oncological imaging, DeepHealth—a subsidiary of the national diagnostic imaging leader RadNet—has...
Treatment Innovations
The $400 Billion Question: Wall Street Rejects Potential AstraZeneca-Bristol Myers Squibb Megamerger
The $400 Billion Question: Wall Street Rejects Potential AstraZeneca-Bristol Myers Squibb Megamerger
In a development that has sent shockwaves through the global pharmaceutical landscape, rumors of a potential megamerger...
In a move that signals a significant pivot toward integrated healthcare solutions, California-based digital health innovator Profusa...
The federal 340B Drug Pricing Program, once a niche mechanism designed to help safety-net providers stretch thin...
In a move set to redefine the landscape of pulmonary oncology, Median Technologies has announced a strategic...
More than six decades after chemist Calvin Stevens first synthesized ketamine at Parke-Davis—an endeavor initially aimed at...
In a significant development for the field of cardiovascular surgery, Total Flow Medical has announced that it...
In the high-stakes world of biopharmaceutical manufacturing, the phrase "tech transfer" is often treated as a logistical...
Executive Summary: Financial Performance in the Wake of Crisis Stryker Corporation, a global leader in medical technology,...
For decades, the KRAS gene—a critical driver of cellular growth—was considered the "Holy Grail" of oncology, yet...
